Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) Return on Equity: 2010-2025

Historic Return on Equity for UNITED THERAPEUTICS (UTHR) over the last 15 years, with Sep 2025 value amounting to 0.18%.

  • UNITED THERAPEUTICS's Return on Equity changed negligibly% to 0.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 0.19% for FY2024, which is 1.00% up from last year.
  • Per UNITED THERAPEUTICS's latest filing, its Return on Equity stood at 0.18% for Q3 2025, which was up 4.00% from 0.18% recorded in Q2 2025.
  • Over the past 5 years, UNITED THERAPEUTICS's Return on Equity peaked at 0.19% during Q2 2024, and registered a low of 0.12% during Q1 2021.
  • Its 3-year average for Return on Equity is 0.18%, with a median of 0.18% in 2025.
  • As far as peak fluctuations go, UNITED THERAPEUTICS's Return on Equity decreased by 7bps in 2021, and later grew by 5bps in 2022.
  • Quarterly analysis of 5 years shows UNITED THERAPEUTICS's Return on Equity stood at 0.12% in 2021, then increased by 3bps to 0.16% in 2022, then grew by 1bps to 0.17% in 2023, then increased by 2bps to 0.19% in 2024, then remained steady at 0.18% in 2025.
  • Its last three reported values are 0.18% in Q3 2025, 0.18% for Q2 2025, and 0.18% during Q1 2025.